Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Respiratory Disease Testing Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence of respiratory diseases
5.1.1.2. Adoption of unhealthy lifestyle and habits such as tobacco smoking
5.1.1.3. Constantly rising air pollution levels
5.1.1.4. Major adoption of imaging technology for diagnostics
5.1.2. Restraints
5.1.2.1. Availability of alternatives systems and devices
5.1.3. Opportunities
5.1.3.1. Rising preferences for remote or home care testing devices
5.1.3.2. R&D and technology advancements in testing methods for effective, efficient, and faster results
5.1.4. Challenges
5.1.4.1. Lack of supportive reimbursement policies
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Respiratory Disease Testing Market, by Product
6.1. Introduction
6.2. Blood Gas Test
6.3. Imaging Tests
6.4. Respiratory Measurement

7. Respiratory Disease Testing Market, by End-Use
7.1. Introduction
7.2. Clinical Laboratories
7.3. Hospitals
7.4. Physician Clinics

8. Americas Respiratory Disease Testing Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Respiratory Disease Testing Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Respiratory Disease Testing Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Abbott Laboratories
12.1.2. Becton, Dickinson and Company
12.1.3. Bio-Rad Laboratories, Inc.
12.1.4. Biom?rieux
12.1.5. Cosmed
12.1.6. F. Hoffmann-La Roche Ltd.
12.1.7. Fujifilm Holdings
12.1.8. GE Healthcare
12.1.9. Hitachi Medical Corporation
12.1.10. Koninklijke Philips N.V
12.1.11. Medtronic PLC
12.1.12. MGC Diagnostics Corporation by Caire Inc.
12.1.13. ResMed
12.1.14. SDI Diagnostics, Inc.
12.1.15. Seegene Inc.
12.1.16. Thermo Fisher Scientific
12.2. Key Product Portfolio

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing



List of Figures

FIGURE 1. RESPIRATORY DISEASE TESTING MARKET RESEARCH PROCESS
FIGURE 2. RESPIRATORY DISEASE TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. RESPIRATORY DISEASE TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. RESPIRATORY DISEASE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. RESPIRATORY DISEASE TESTING MARKET DYNAMICS
FIGURE 7. RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 10. RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS RESPIRATORY DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS RESPIRATORY DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC RESPIRATORY DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC RESPIRATORY DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. RESPIRATORY DISEASE TESTING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. RESPIRATORY DISEASE TESTING MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. RESPIRATORY DISEASE TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. RESPIRATORY DISEASE TESTING MARKET SIZE, BY BLOOD GAS TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. RESPIRATORY DISEASE TESTING MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. RESPIRATORY DISEASE TESTING MARKET SIZE, BY RESPIRATORY MEASUREMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 10. RESPIRATORY DISEASE TESTING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. RESPIRATORY DISEASE TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. RESPIRATORY DISEASE TESTING MARKET SIZE, BY PHYSICIAN CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. AMERICAS RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS RESPIRATORY DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 16. ARGENTINA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 17. ARGENTINA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 18. BRAZIL RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 19. BRAZIL RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 20. CANADA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 21. CANADA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 22. MEXICO RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 23. MEXICO RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 27. ASIA-PACIFIC RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 28. ASIA-PACIFIC RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 29. ASIA-PACIFIC RESPIRATORY DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. AUSTRALIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. AUSTRALIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 32. CHINA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 33. CHINA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 34. INDIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. INDIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 36. INDONESIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. INDONESIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 38. JAPAN RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 39. JAPAN RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 40. MALAYSIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. MALAYSIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 42. PHILIPPINES RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. PHILIPPINES RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 44. SINGAPORE RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. SINGAPORE RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 46. SOUTH KOREA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. SOUTH KOREA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 48. TAIWAN RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. TAIWAN RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 50. THAILAND RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. THAILAND RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 52. VIETNAM RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. VIETNAM RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. DENMARK RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. DENMARK RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 59. EGYPT RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. EGYPT RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 61. FINLAND RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. FINLAND RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 63. FRANCE RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. FRANCE RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 65. GERMANY RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. GERMANY RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 67. ISRAEL RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. ISRAEL RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 69. ITALY RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. ITALY RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 71. NETHERLANDS RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. NETHERLANDS RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 73. NIGERIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. NIGERIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 75. NORWAY RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. NORWAY RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 77. POLAND RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. POLAND RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 79. QATAR RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. QATAR RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 83. SAUDI ARABIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. SAUDI ARABIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 85. SOUTH AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. SOUTH AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 87. SPAIN RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. SPAIN RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 89. SWEDEN RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. SWEDEN RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 91. SWITZERLAND RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. SWITZERLAND RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 93. TURKEY RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. TURKEY RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 99. RESPIRATORY DISEASE TESTING MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 100. RESPIRATORY DISEASE TESTING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 101. RESPIRATORY DISEASE TESTING MARKET LICENSE & PRICING